Trinity Biotech (TRIB) Cash from Investing Activities (2021 - 2024)
Historic Cash from Investing Activities for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to -$2.7 million.
- Trinity Biotech's Cash from Investing Activities fell 20707.07% to -$2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$5.7 million, marking a year-over-year decrease of 3330.97%. This contributed to the annual value of -$23.0 million for FY2024, which is 19277.75% down from last year.
- According to the latest figures from Q4 2024, Trinity Biotech's Cash from Investing Activities is -$2.7 million, which was down 20707.07% from -$891000.0 recorded in Q4 2023.
- In the past 5 years, Trinity Biotech's Cash from Investing Activities ranged from a high of -$1801.0 in Q2 2022 and a low of -$2.7 million during Q4 2024
- Its 4-year average for Cash from Investing Activities is -$1.2 million, with a median of -$1.0 million in 2022.
- In the last 5 years, Trinity Biotech's Cash from Investing Activities soared by 5402.02% in 2022 and then crashed by 20707.07% in 2024.
- Quarter analysis of 4 years shows Trinity Biotech's Cash from Investing Activities stood at -$2.5 million in 2021, then surged by 54.02% to -$1.1 million in 2022, then grew by 21.7% to -$891000.0 in 2023, then tumbled by 207.07% to -$2.7 million in 2024.
- Its Cash from Investing Activities was -$2.7 million in Q4 2024, compared to -$891000.0 in Q4 2023 and -$886000.0 in Q3 2023.